Form 4: AIM ImmunoTech Inc. Executive Acquires Additional Shares

Peter W. Rodino III, COO, Secretary, and General Counsel of AIM ImmunoTech Inc., purchased 500 shares of common stock at $0.087 per share on April 4, 2025.

Summary

• On April 4, 2025, Peter W. Rodino III, the COO, Secretary, and General Counsel of AIM ImmunoTech Inc., acquired 500 shares of the company's common stock.
• The shares were purchased at a price of $0.087 per share.
• Following this transaction, Rodino directly owns 401,762 shares of AIM ImmunoTech Inc.

Sentiment

Score: 6

Explanation: Neutral sentiment. It's a routine disclosure of an insider stock purchase. While insider buying can be seen as a positive signal, the small number of shares purchased doesn't necessarily indicate a strong bullish outlook.

Positives

• An executive's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This is a standard SEC Form 4 filing, which is required when an insider of a publicly traded company buys or sells the company's securities. It provides transparency into the transactions of company executives and directors.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment, as it signals confidence from a company executive.

Key Dates

Keywords

AIM ImmunoTech Inc., insider trading, Form 4, stock acquisition, beneficial ownership, Rodino, executive, shares